Table 1 Socio-demographic and clinical characteristics of the participants (N = 343)
Characteristic | N | % |
|---|---|---|
Sex | ||
 Male | 87 | 25.4 |
 Female | 256 | 74.6 |
Ethnicity | ||
 Chinese | 269 | 78.4 |
 Non-Chinese Asian | 31 | 9.0 |
 Caucasian | 43 | 12.5 |
Cancer diagnosis | ||
 Breast cancer | 174 | 50.7 |
 Lung cancer | 48 | 14.0 |
 Gynecological cancer | 46 | 13.4 |
 Head & Neck cancer | 30 | 8.7 |
 Gastrointestinal cancer | 29 | 8.5 |
 Urinary tract cancer | 16 | 4.7 |
Cancer stage | ||
 I | 52 | 15.2 |
 II | 99 | 28.9 |
 III | 116 | 33.8 |
 IV | 76 | 22.2 |
Treatment intent | ||
 Curative | 250 | 72.9 |
 Definitive | 30 | 8.7 |
 Palliative | 63 | 18.4 |
Type of chemotherapy | ||
 Taxane | 155 | 45.2 |
 Platinum | 109 | 31.8 |
 Combination of taxane plus platinum | 79 | 23.0 |
Chemotherapy protocol | ||
 Docetaxel | 122 | 35.6 |
 Paclitaxel | 33 | 9.7 |
 Cisplatin/Carboplatin | 80 | 23.4 |
 Oxaliplatin | 28 | 8.3 |
 Carboplatin+Paclitaxel | 49 | 14.4 |
 Carboplatin+Docetaxel | 29 | 8.6 |